Al. Schneyer et al., CHARACTERIZATION OF UNIQUE BINDING-KINETICS OF FOLLISTATIN AND ACTIVIN OR INHIBIN IN SERUM, Endocrinology, 135(2), 1994, pp. 667-674
Serum binding proteins (BPs) have been identified for several peptide
and protein hormones, and their presence has significant implications
for the biological action of the hormone. Follistatin (FS) has been id
entified as an activin- and inhibin-BP in tissues, serum, and follicul
ar fluid of several species, including humans. In this study, the bind
ing kinetics of FS for activin and inhibin were characterized in human
serum using gel filtration chromatography and compared to those of pu
re recombinant hormones using chromatography and a new solid phase ass
ay. When complexed with radiolabeled activin or inhibin, FS eluted at
a volume corresponding to a mol wt range of 67,000-150,000, an elution
volume identical to the lower mol wt BP peak observed in serum. Furth
ermore, kinetic analyses of recombinant FS binding to activin using a
solid phase assay revealed that 1) the FS-activin interaction is of hi
gh affinity, similar to or exceeding that estimated for activin bindin
g to its receptor; 2) binding to activin is essentially irreversible a
t physiological pH; and 3) the potency of inhibin is approximately 500
- to 1000-fold lower than that of activin in the FS binding assay. The
lack of FS-[I-125]activin complex reversibility observed in the solid
phase assay was confirmed using a modified gel filtration chromatogra
phy protocol. Thus, preincubation of pure FS or serum with unlabeled a
ctivin for 2 h eliminated all binding of subsequently added labeled ac
tivin despite a much longer incubation period. However, when labeled a
ctivin was incubated with FS for 2 h, subsequent addition of unlabeled
activin or inhibin was unable to displace labeled activin from FS, ag
ain demonstrating a lack of reversibility. Finally, to map this high a
ffinity interaction, overlapping synthetic peptides were used to compe
te with labeled activin for FS binding. Two potential contact sites be
tween FS and activin were identified, one near the N-terminus (amino a
cids 15-29) and the other near the C-terminus (amino acids 99-116). Gi
ven its apparently irreversible nature, high affinity, and ability to
neutralize activin's biological activity, FS is quite different from t
he typical hormone-BP. These unique properties of FS undoubtedly attes
t to the potency of activin in many physiological and developmental se
ttings and, therefore, to the importance of BPs, such as FS for regula
ting activin's bioactivity, distribution, and/or clearance.